FDA — authorised 12 November 1957
- Application: NDA010996
- Marketing authorisation holder: XANODYNE PHARM
- Local brand name: DARVON W/ ASA
- Indication: CAPSULE — ORAL
- Status: approved
🇺🇸 ASA evening in United States
FDA authorised ASA evening on 12 November 1957
Marketing authorisations
FDA — authorised 9 September 1971
- Application: NDA016829
- Marketing authorisation holder: AAIPHARMA LLC
- Local brand name: DARVON-N W/ ASA
- Indication: CAPSULE — ORAL
- Status: approved
FDA — authorised 9 September 1971
- Application: NDA016863
- Marketing authorisation holder: AAIPHARMA LLC
- Local brand name: DARVON-N W/ ASA
- Indication: TABLET — ORAL
- Status: approved
Other Cardiovascular approved in United States
Frequently asked questions
Is ASA evening approved in United States?
Yes. FDA authorised it on 12 November 1957; FDA authorised it on 9 September 1971; FDA authorised it on 9 September 1971.
Who is the marketing authorisation holder for ASA evening in United States?
XANODYNE PHARM holds the US marketing authorisation.